Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHARMA > ANTIVIRAL > Flashcards

ANTIVIRAL Flashcards

1
Q

Potent and selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface.

Oseltamivir
Enfuvirtide
Amantadine
Darunavir

A

Oseltamivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Binds to the first heptad-repeat (HR1) in the gp41 subunit of the viral envelope glycoprotein and prevents the conformational changes required for the fusion of viral and cellular membranes.

Enfuvirtide
Ritonavir
Nirmatrelvir
Acyclovir

A

Enfuvirtide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become “uncoated” once it is taken inside the cell by endocytosis.

Enfuvirtide
Ritonavir
Amantadine
Foscarnet

A

Amantadine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A HIV protease inhibitor, prevents HIV replication through binding to the enzyme, stopping the dimerization and the catalytic activity of HIV-1 protease

it inhibits the cleavage of HIV encoded Gag-Pol proteins in cells that have been infected with the virus

Enfuvirtide
Darunavir
Ritonavir
Nirmatrelvir

A

Darunavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Potent inhibitor of cytochrome P450 CYP3A4 isoenzyme present both in the intestinal tract and liver

Enfuvirtide
Darunavir
Ritonavir
Nirmatrelvir

A

Ritonavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

has higher affinity for viral DNA polymerase than cellular DNA polymerase and incorporates into the DNA where the missing 2’ and 3’ carbons causes DNA chain termination.

competes so strongly for viral DNA polymerase that other bases cannot associate with the enzyme, inactivating it

Acyclovir
Foscarnet
Remdesivir
lamivudine

A

acyclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

selective inhibition at the pyrophosphate binding site on virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases.

Acyclovir
Foscarnet
Remdesivir
lamivudine

A

Foscarnet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Directly inhibits viral mRNA polymerase by binding to the nucleotide binding site of the enzyme

demonstrates an inhibitory action on viral mRNA guanylyltransferase and mRNA 2′-O-methyltransferase of dengue virus

Foscarnet
ribavirin
Remdesivir
lamivudine

A

ribavirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Binds to the viral RNA-dependent RNA polymerase, inhibiting viral replication through premature termination of RNA transcription

Foscarnet
ribavirin
Remdesivir
lamivudine

A

Remdesivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A synthetic nucleoside analogue and is phosphorylated intracellularly to its active 5’-triphosphate metabolite,

This nucleoside analogue is incorporated into viral DNA by HIV reverse transcriptase and HBV polymerase, resulting in DNA chain termination.

Foscarnet
ribavirin
Remdesivir
lamivudine

A

lamivudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Potent inhibitor of the viral reverse transcriptase

Remdesivir
lamivudine
tenofovir
efavirenz

A

tenofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1).

It directly binds reverse transcriptase and consequently blocks DNA-dependent and RNA-dependent polymerase activity

Remdesivir
lamivudine
Etravirine
efavirenz

A

Etravirine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhibits HIV integrase to prevent the viral genome being incorporated into the human genome.

Etravirine
Raltegravir
Nucleozin
Interferon

A

Raltegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Targets influenza A nucleoprotein, a multifunctional, RNA-binding protein necessary for virus replication. It induces the formation of nucleoptotein aggregates and inhibits its accumulation, interfering with viral replication

Etravirine
Raltegravir
Nucleozin
Interferon

A

Nucleozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Targets and inhibits human host cyclophilins, thereby inhibiting hepatitis C virus (HCV) replication in hepatocytes.

Alisporivir
Aplaviroc
Nucleozin
Interferon

A

Alisporivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours

prophylaxis of influenza in patients one year and older

A

OSELTAMIVIR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

S/E OSELTAMIVIR

A

Nausea, vomiting, psychiatric effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Enveloped viruses penetrate by fusion of the viral membrane with the cell membrane, while “naked” viruses penetrate the cell by phagocytosis of the virion and releasing viral genome into the host cytoplasm.

A

ENTRY INHIBITORS

19
Q

ENTRY INHIBITORS THAT ARE ANTI HIV

A

Enfuvirtide, Sifuvirtide

20
Q

Human rhinovirus inhibitor

amantadine
pleconaril
enfuvirtide
oseltamivir

A

Pleconaril

21
Q

Used in combination therapy for the treatment of HIV-1/AIDS

amantadine
pleconaril
enfuvirtide
oseltamivir

A

enfuvirtide

22
Q

adverse reaction of enfuvirtide

A
  • Injection site reactions (pain, hardening of skin,erythema,nodules,cysts, itch)
  • Peripheral neuropathy, insomnia, depression, cough, dyspnea,anorexia,arthralgia, infections (including bacterialpneumonia), and/oreosinophilia
  • Hypersensitivity reactions
23
Q

Another antiviral drug target is the uncoating step during viral infection, which is the process of capsid disintegration, retaining the virus in the encapsulated state, and not allowing the virus to release its genomic material into the host cell to interrupt the virus replicative cycle before it proceeds to the reverse transcriptase step.

A

UNCOATING INHIBITORS

Amantadine, Rimantadine

24
Q
  • For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus.
  • Also, for the treatment of parkinsonism and drug-induced extrapyramidal reactions.
A

Amantadine

25
Q

adverse effect of amantadine

A
  • Orthostatic hypotension, syncope, peripheral edema, dizziness, delusions, hallucinations, falls, xerostomia, and constipation
  • Serious adverse effects include neuroleptic malignant syndrome, psychosis, suicidal ideation, and CNS depression
26
Q

prevent viral replication by blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious particles. It should be noted that most viruses also encode proteases, which protect viral proteins by modulating host cell.

A

Protease inhibitors

27
Q

protease inhibitor that are Anti-HIV

A

Nelfinavir, Amprenavir, Fosamprenavir, Darunavir, Saquinavir, Atazanavir, Indinavir, Lopinavir, Ritonavir, Tipranavir, Simeprevir

28
Q

protease inhibitor that is used for COVID

A

Nirmatrelvir

29
Q

indication of this drug

  • co-administered with ritonavir, and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV) in children age 3 or above and adults with HIV-1 infection.

amantadine
enfuvirtide
acyclovir
darunavir

A

darunavir

30
Q

adverse effect of darunavir

A

> 10%:
Dermatologic: Skin rash

Endocrine & metabolic: Increased serum cholesterol, increased LDL cholesterol, increased serum glucose

Gastrointestinal: Vomiting, nausea, diarrhea

31
Q

Has received FDA emergency use authorization, in combination with ritonavir, for the treatment of Mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients
12 years of age and older weighing at least 40 kg
With positive results of direct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing
Who are at high risk for progression to severe COVID-19, including hospitalization or death.

a, acyclovir
b. nirmatrelvir
c. darunavir
d. ritonavir

A

b. nirmatrelvir

32
Q

nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use

A

paxlovid

not authorized for use for longer than five consecutive days.

33
Q

side effects of Paxlovid include

A
  • Impaired sense of taste, diarrhea, high blood pressure and muscle aches
  • In people with uncontrolled or undiagnosed HIV-1 infection may lead to HIV-1 drug resistance
  • Ritonavir may cause liver damage, so caution should be exercised when giving Paxlovid to patients with preexisting liver diseases, liver enzyme abnormalities or liver inflammation.
34
Q

the drug of choice for the prophylactic and curative treatment of herpes simplex (genital herpes) virus and varicella-zoster (shingles) virus infection

acyclovir
valcyclovir
Valganciclovir

A

acyclovir

35
Q

used for the treatment of herpes, varicella zoster, and cytomegaloviruses

acyclovir
valcyclovir
Valganciclovir

A

valcyclovir

36
Q

used for the treatment of herpes, varicella zoster, and cytomegaloviruses

acyclovir
valcyclovir
Valganciclovir

A

valcyclovir

37
Q

is effective for the treatment of AIDS-related CMV retinitis, and for the prophylaxis of cytomegalovirus infection and disease in high-risk solid organ transplant recipients.

acyclovir
valganciclovir
valacyclovir

A

valganciclovir

38
Q

Used to treat herpes simplex,Varicella zoster, herpes zoster, herpes labialis, and acute herpetic keratitis

A

ACYCLOVIR

  • acyclovir topical cream is indicated to treat recurrent herpes labialis in immunocompetent patients 12 years and older.
  • An acyclovir ophthalmic ointment is indicated to treat acute herpetic keratitis.
  • Acyclovir oral tablets, capsules, and suspensions are indicated to treat herpes zoster, genital herpes, and chickenpox.
39
Q

ADVERSER EFFECT OF ACYCLOVIR USE

A

Nausea, vomiting, diarrhea,encephalopathy(with IV use only), injection site reactions (with IV use only) and headache

40
Q

ADVERSER EFFECT OF ACYCLOVIR USE

A

Nausea, vomiting, diarrhea,encephalopathy(with IV use only), injection site reactions (with IV use only) and headache

41
Q
  • For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
A

foscarnet

42
Q
  • For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
A

foscarnet

43
Q

ADVERSE EFFECT OF FOSCARNET

A
  1. Nephrotoxicity— Increase in serum creatinine levels occurs on average in 45% of patients receiving foscarnet. Other nephrotoxic drugs should be avoided. Nephrotoxicity is usually reversible and can be reduced by dosage adjustment and adequate hydration.
  2. Electrolytedisturbances — Changes in calcium, magnesium, potassium and phosphate levels occurs commonly and regular monitoring of electrolytes is necessary to avoid clinical toxicity
  3. Genitalulceration— Occurs more commonly in men and usually occurs during induction use of foscarnet. It is most likely a contact dermatitis due to high concentrations of foscarnet in urine. It usually resolves rapidly following discontinuation of the drug.
  4. CNS —Paresthesia,irritabilityandhallucinations.

PHARMA (29 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions